Summary of Key Information:
Reporting Period (Quarter/Year): Quarter and Half Year ended September 30, 2026 (Q2 FY27, H1 FY27)
Nature of Filing / Announcement: Outcome of Board Meeting
Audit Opinion:
Clean (Unqualified)
The Independent Auditor's Limited Review Report states: "Based on our review conducted as stated above, nothing has come to our attention that causes us to believe that the accompanying Statement of unaudited financial results... contains any material misstatement."
Key Financial Highlights [Rs. In Lakhs]
Standalone Results:
Quarter Ended September 30, 2026 (Q2 FY27):
- Revenue from Operations: ₹11,348.49 (vs ₹8,394.32 in Q2 FY25 - YoY increase; vs ₹9,827.58 in Q1 FY27 - QoQ increase)
- Total Income: ₹11,370.44
- Net Profit: ₹897.78 (vs ₹650.67 in Q1 FY27 - QoQ increase)
- EPS: Basic and Diluted ₹0.23
Half Year Ended September 30, 2026 (H1 FY27):
- Revenue from Operations: ₹21,176.08 (vs ₹19,491.97 in H1 FY25)
- Total Income: ₹21,242.36
- Net Profit: ₹1,548.45
- EPS: Basic and Diluted ₹0.41
Consolidated Results:
Quarter Ended September 30, 2026 (Q2 FY27):
- Revenue from Operations: ₹13,045.54 (vs ₹11,048.44 in Q2 FY25 - YoY increase; vs ₹12,127.38 in Q1 FY27 - QoQ increase)
- Total Income: ₹13,067.90
- Net Profit: ₹878.40
- EPS: Basic and Diluted ₹0.27
Half Year Ended September 30, 2026 (H1 FY27):
- Revenue from Operations: ₹25,172.92 (vs ₹23,873.06 in H1 FY25)
- Total Income: ₹25,295.57
- Net Profit: ₹1,692.87
- EPS: Basic and Diluted ₹0.44
Balance Sheet Highlights (Standalone as at September 30, 2026):
- Total Assets: ₹75,430.75 lakhs (vs ₹72,470.86 lakhs as at March 31, 2026)
- Equity Share Capital: ₹3,821.17 lakhs
- Other Equity: ₹45,333.26 lakhs
- Total Equity: ₹49,154.43 lakhs
- Cash and Cash Equivalents: ₹511.51 lakhs
- Other Bank Balances: ₹511.22 lakhs
- Total Borrowings: ₹11,619.29 lakhs (Short-term)
- Lease Liabilities: ₹2,089.08 lakhs (Non-current) + ₹397.87 lakhs (Current)
Cash Flow Statement (Standalone for H1 FY27):
- Cash Flow from Operating Activities: ₹97.55 lakhs
- Cash Flow from Investing Activities: ₹(1,827.31) lakhs
- Cash Flow from Financing Activities: ₹952.96 lakhs
- Net decrease in Cash and Cash Equivalents: ₹(776.79) lakhs
Segment-wise Performance [Rs. In Lakhs]:
Standalone (Q2 FY27):
- Pharmaceuticals Segment Revenue: ₹9,954.87
- Pharmaceuticals Segment Profit before tax and interest: ₹1,168.91
- Operational and Management Segment Revenue: ₹1,393.63
- Operational and Management Segment Profit before tax and interest: ₹198.74
Consolidated (Q2 FY27):
- Pharmaceuticals Segment Revenue: ₹11,651.92
- Pharmaceuticals Segment Profit before tax and interest: ₹1,293.01
- Operational and Management Segment Revenue: ₹1,393.63
- Operational and Management Segment Profit before tax and interest: ₹198.74
Corporate Actions:
The Board approved the appointment of:
1. Mr. Awanindra Kumar Singh (DIN: 07123593) as Additional Whole-Time Director (Professional, Executive) for a period of two consecutive years effective from October 31, 2026, subject to member approval.
2. Mr. Sridhara Narasimha Sastry (DIN: 12027485) as Additional Independent Director (Non-Executive) for a first term of two consecutive years effective from October 31, 2026, subject to member approval.
A Postal Ballot Notice will be issued to shareholders for approval of these appointments.
Other Significant Information:
- The company has subsidiaries: Sigachi US INC, Sigachi MENA FZCO, and Trimax Bio Sciences Private Limited
- Previous period figures have been regrouped and recast wherever necessary
Profiles of New Directors:
Mr. Awanindra Kumar Singh: Seasoned pharmaceutical professional with over 35 years of experience in pharmaceutical manufacturing, operations, process improvement, and product development. M.Sc (Organic Chemistry) and Masters in Chemical Engineering.
Mr. Sridhara Narasimha Sastry: Seasoned senior professional in the chemical industry with over 39 years of experience across operations, technology, process safety, sustainability, and corporate governance. Previously President & Unit Head at Grasim Industries Limited (Aditya Birla Group). Harvard Business School's Global Strategy Programme graduate and ICF-certified Executive Coach.
Both directors are not related to any existing director of the company and are not debarred from holding office by SEBI or any other authority.